Hom David B, Thatcher Gentry, Tibesar Robert
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Minnesota School of Medicine and Hennepin County Medical Center, Minneapolis, MN 55455, USA.
Facial Plast Surg. 2002 Feb;18(1):41-52. doi: 10.1055/s-2002-19826.
The advent of new U.S. Food and Drug Administration-approved products containing growth factors to improve soft tissue healing signifies a new era for wound healing. Over the last decade, some clinical growth factor studies have been promising, whereas others have not shown any positive effect. What many of these studies have shown is that the state of a healing wound is not only dependent on its growth factor milieu but also on other variables (wound care, tissue oxygen state, bacteria count, and nutritional status of the patient). This article describes recent progress with growth factors on soft tissue structures (skin, mucosa, and nerve) relevant to the facial plastic and reconstructive surgeon.
美国食品药品监督管理局批准的含有生长因子以促进软组织愈合的新产品的出现,标志着伤口愈合进入了一个新时代。在过去十年中,一些临床生长因子研究成果喜人,而另一些则未显示出任何积极效果。这些研究大多表明,伤口愈合的状态不仅取决于其生长因子环境,还取决于其他变量(伤口护理、组织氧状态、细菌数量和患者的营养状况)。本文介绍了生长因子在与面部整形和重建外科医生相关的软组织结构(皮肤、黏膜和神经)方面的最新进展。